Smoking in infertile women with polycystic ovary syndrome: Baseline validation of self-report and effects on phenotype

Human Reproduction

Volumn 29, Issue 12, 2014, Pages 2680-2686

  Legro, Richard S ^a   Chen, Gang ^a   Kunselman, Allen R ^a   Schlaff, William D ^b   Diamond, Michael P ^c   Coutifaris, Christos ^d   Carson, Sandra A ^e   Steinkampf, Michael P ^f   Carr, Bruce R ^g   Mcgovern, Peter G ^h   Cataldo, Nicholas A ⁱ   Gosman, Gabriella G ^j   Nestler, John E ^k   Myers, Evan R ^l   Zhang, Heping ^m   Foulds, Jonathan ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF TEXAS AT DALLAS   (United States)

^h UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^k VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m YALE UNIVERSITY   (United States)

more..

Author keywords

anovulation; cigarette smoking; hyperandrogenism; infertility; obesity

Indexed keywords

CLOMIFENE; COTININE; INSULIN; METFORMIN; TESTOSTERONE;

ADULT; ANOVULATION; ARTICLE; BIRTH RATE; CASE CONTROL STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLOW UP; HELP SEEKING BEHAVIOR; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVE BIRTH; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SMOKING; TESTOSTERONE BLOOD LEVEL; ADOLESCENT; BLOOD; COMPLICATION; EPIDEMIOLOGY; SELF DISCLOSURE; VALIDATION STUDY;

ADOLESCENT; ADULT; COTININE; FEMALE; HUMANS; INFERTILITY, FEMALE; INSULIN RESISTANCE; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; SELF DISCLOSURE; SMOKING;

EID: 84929615895     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu239     Document Type: Article

References (19)

1. Bachen EA, Muldoon MF, Matthews KA, Manuck SB. Effects of hemoconcentration and sympathetic activation on serum lipid responses to brief mental stress. Psychosom Med. 2002; 64: 587-594
2. Cupisti S, Haberle L, Dittrich R, Oppelt PG, Reissmann C, Kronawitter D, Mueller A. Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance. Fertil Steril. 2010; 94: 673-677
3. Dietz PM, Homa D, England LJ, Burley K, Tong VT, Dube SR, Bernert JT. Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. Am J Epidemiol. 2011; 173: 355-359
4. Glintborg D, Mumm H, Hougaard DM, Ravn P, Andersen M. Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome. Gynecol Endocrinol. 2012; 28: 170-174
5. Gorber SC, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-Assessed smoking status. Nicotine Tob Res. 2009; 11: 12-24
6. Hughes EG, Lamont DA, Beecroft ML, Wilson DM, Brennan BG, Rice SC. Randomized trial of a 'stage-of-change' oriented smoking cessation intervention in infertile and pregnant women. Fertil Steril. 2000; 74: 498-503
7. Legro RS, Myers ER, Barnhart HX, Carson SA, Diamond MP, Carr BR, Leppert PC. The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril. 2006; 86: 914-933
8. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Myers ER. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007; 356: 551-566
9. Pasch LA, Gregorich SE, Katz PK, Millstein SG, Nachtigall RD, Bleil ME, Adler NE. Psychological distress and in vitro fertilization outcome. Fertil Steril. 2012; 98: 459-464
10. Pau CT, Keefe CC, Welt CK. Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome. Gynecol Endocrinol. 2013; 29: 551-555
11. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998; 316: 1236-1238
12. Rausch ME, Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Coutifaris C. Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009; 94: 3458-3466
13. Rosevear SK, Holt DW, Lee TD, Ford WC, Wardle PG, Hull MG. Smoking and decreased fertilisation rates in vitro. Lancet. 1992; 340: 1195-1196
14. Shipton D, Tappin DM, Vadiveloo T, Crossley JA, Aitken DA, Chalmers J. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study. BMJ. 2009; 339: b4347
15. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002; 4: 149-159
16. Tomeo CA, Field AE, Berkey CS, Colditz GA, Frazier AL.Weight concerns, weight control behaviors, and smoking initiation. Pediatrics. 1999; 104(4 Pt 1): 918-924
17. Triche EW, Hossain N. Environmental factors implicated in the causation of adverse pregnancy outcome. Semin Perinatol. 2007; 31: 240-242
18. U.S. Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Rockville, MD: Public Health Service, Office of Surgeon General. (2010). Winter E, Wang J, Davies MJ, Norman R. Early pregnancy loss following assisted reproductive technology treatment. Hum Reprod. 2002; 17: 3220-3223
19. Wong SL, Malaison E, Hammond D, Leatherdale ST. Secondhand smoke exposure among Canadians: cotinine and self-report measures from the Canadian Health Measures Survey 2007-2009. Nicotine Tob Res. 2013; 15: 693-700